Symphony Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Symphony Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,259	Closed	-$326K	–	403
2015 Q4	$326K	Sell	5,259 -2,046	-28%	-$110K	0.04%	349
2015 Q3	$296K	Buy	+7,305	New	+$378K	0.04%	385
2015 Q2	–	Sell	-6,836	Closed	-$436K	–	451
2015 Q1	$436K	Buy	+6,836	New	+$464K	0.05%	355
2014 Q3	–	Sell	-13,650	Closed	-$470K	–	418
2014 Q2	$470K	Buy	13,650 +7,860	+136%	+$247K	0.05%	324
2014 Q1	$250K	Buy	+5,790	New	+$281K	0.02%	389

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Symphony Asset Management's IONS Position: Q1 2016 in Review

Symphony Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2016, closing a stake of 5,259 shares — an estimated $326K sold.

Symphony Asset Management first reported a position in IONS in Q1 2014 and held it in 5 quarters. The position peaked at $470K in Q2 2014. 314 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

Symphony Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Symphony Asset Management sold 5,259 Ionis Pharmaceuticals shares in Q1 2016, an estimated $326K.
Symphony Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 5 quarters.
Symphony Asset Management's Ionis Pharmaceuticals position peaked at $470K in Q2 2014.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Symphony Asset Management's 13F filing for Q1 2016, filed 13 May 2016.